Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF

Leukemia Research

Volumn 34, Issue 3, 2010, Pages 312-321

  Maffei, Rossana ^a   Martinelli, Silvia ^a   Castelli, Ilaria ^a   Santachiara, Rita ^a   Zucchini, Patrizia ^a   Fontana, Marcella ^a   Fiorcari, Stefania ^a   Bonacorsi, Goretta ^a   Ilariucci, Fiorella ^b   Torelli, Giuseppe ^a   Marasca, Roberto ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Hematology Unit   (Italy)

Author keywords

Angiogenesis; Angiogenesis related factors; CLL; Endothelial cells; Hypoxia; Microenvironment

Indexed keywords

ANGIOPOIETIN 2; CD34 ANTIGEN; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ANTIANGIOGENIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CELL COMPARTMENTALIZATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMOGENESIS; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; ANTIGENS, CD34; BONE MARROW; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77649190207     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.06.023     Document Type: Article

References (46)

1. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
2. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284:1994-1998.
3. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
4. Koh G.Y., Kim I., Kwak H.J., Yun M.J., Leem J.C. Biomedical significance of endothelial cell specific growth factor, angiopoietin. Exp Mol Med 2002, 34:1-11.
5. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182-1186.
6. Perez-Atayde A.R., Sallan S.E., Tedrow U., Connors S., Allred E., Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997, 150:815-821.
7. Padró T., Ruiz S., Bieker R., Bürger H., Steins M., Kienast J., et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000, 95:2637-2644.
8. Munk Pedersen I., Reed J. Microenvironmental interactions and survival of CLL B-cells. Leuk Lymphoma 2004, 45:2365-2372.
9. Shanafelt T.D., Kay N.E. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol 2006, 33:174-185.
10. Letilovic T., Vrhovac R., Verstovsek S., Jaksic B., Ferrajoli A. Role of angiogenesis in chronic lymphocytic leukemia. Cancer 2006, 107:925-934.
11. Chen H., Treweeke A.T., West D.C., Till K.J., Cawley J.C., Zuzel M., et al. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood 2000, 96:3181-3187.
12. Kini A.R., Kay N.E., Peterson L.C. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000, 14:1414-1418.
13. Molica S., Vacca A., Ribatti D., Cuneo A., Cavazzini F., Levato D., et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 2002, 100:3344-3351.
14. Peterson L., Kini A.R. Angiogenesis is increased in B-cell chronic lymphocytic leukemia. Blood 2001, 97:2529.
15. Smolej L., Andrys C., Peková S., Schwarz J., Belada D., Zák P. Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia. Haematologica 2006, 91:1432-1433.
16. McCabe D., Bacon L., O'Regan K., Condron C., O'Donnell J.R., Murphy P.T. CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression. Leukemia 2004, 18:649-650.
17. Huttmann A., Klein-Hitpass L., Thomale J., Deenen R., Carpinteiro A., Nückel H., et al. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 2006, 20:1774-1782.
18. Maffei R., Marasca R., Martinelli S., Castelli I., Santachiara R., Morandi E., et al. Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status. Leukemia 2007, 21:1312-1315.
19. Molica S., Vitelli G., Levato D., Gandolfo G.M., Liso V. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia. Br J Haematol 1999, 107:605-610.
20. Frater J.L., Kay N.E., Goolsby C.L., Crawford S.E., Dewald G.W., Peterson L.C. Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence. Diagn Pathol 2008, 3:16-43.
21. Kay N.E., Bone N.D., Tschumper R.C., Howell K.H., Geyer S.M., Dewald G.W., et al. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules. Leukemia 2002, 16:911-919.
22. Pichiule P., Chavez J.C., LaManna J.C. Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 2004, 279:12171-12180.
23. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999, 274:15732-15739.
24. Mandriota S.J., Pepper M.S. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998, 83:852-859.
25. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996, 87:4990-4997.
26. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981, 48:198-206.
27. Koga K., Todaka T., Morioka M., Hamada J., Kai Y., Yano S., et al. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res 2001, 61:6248-6254.
28. Ye F.C., Blackbourn D.J., Mengel M., Xie J.P., Qian L.W., Greene W., et al. Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducingangiopoietin-2 expression via AP-1 and Ets1. J Virol 2007, 81:3980-3991.
29. Brown L.F., Dezube B.J., Tognazzi K., Dvorak H.F., Yancopoulos G.D. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 2000, 156:2179-2183.
30. Yu Y., Varughese J., Brown L.F., Mulliken J.B., Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 2001, 159:2271-2280.
31. Bunone G., Vigneri P., Mariani L., Butó S., Collini P., Pilotti S., et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999, 155:1967-1976.
32. Etoh T., Inoue H., Tanaka S., Barnard G.F., Kitano S., Mori M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 2001, 61:2145-2153.
33. Yoshida Y., Oshika Y., Fukushima Y., Tokunaga T., Hatanaka H., Kijima H., et al. Expression of angiostatic factors in colorectal cancer. Int J Oncol 1999, 15:1221-1225.
34. Loges S., Heil G., Bruweleit M., Schoder V., Butzal M., Fischer U., et al. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival. J Clin Oncol 2005, 23:1109-1117.
35. Schliemann C., Bieker R., Padro T., Kessler T., Hintelmann H., Buchner T., et al. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. Haematologica 2006, 91:1203-1211.
36. Uneda S., Matsuno F., Sonoki T., Tniguchi I., Kawano F., Hata H. Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells. Haematologica 2003, 88:113-115.
37. Zagzag D., Hooper A., Friedlander D.R., Chan W., Holash J., Wiegand S.J., et al. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 1999, 159:391-400.
38. Oliner J., Min H., Leal J., Yu D., Rao S., You E., et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 2004, 6:507-516.
39. Villeneuve J., Galarneau H., Beaudet M.J., Tremblay P., Chernomoretz A., Vallières L. Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment. Brain Pathol 2008, 18:401-414.
40. Perry B.N., Govindarajan B., Bhandarkar S.S., Knaus U.G., Valo M., Sturk C., et al. Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol 2006, 126:2316-2322.
41. Kim I., Kim J.H., Ryu Y.S., Jung S.H., Nah J.J., Koh G.Y. Characterization and expression of a novel alternatively spliced human angiopoietin-2. J Biol Chem 2000, 275:18550-18556.
42. Gu J., Yamamoto H., Ogawa M., Ngan C.Y., Danno K., Hemmi H., et al. Hypoxia-induced up-regulation of angiopoietin-2 in colorectal cancer. Oncol Rep 2006, 15:779-783.
43. Sugimachi K., Tanaka S., Taguchi K., Aishima S., Shimada M., Tsuneyoshi M. Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J Clin Pathol 2003, 56:854-860.
44. Currie M.J., Gunningham S.P., Turner K., Han C., Scott P.A., Robinson B.A., et al. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia. J Pathol 2002, 198:502-510.
45. Fiedler U., Scharpfenecker M., Koidl S., Hegen A., Grunow V., Schmidt J.M., et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004, 103:4150-4156.
46. Simon M.P., Tournaire R., Pouyssegur J. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol 2008, 217:809-818.